Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.53771 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.49459 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.49729 | 21 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.44097 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.43811 | 20 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.66132 | 26 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.52985 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.47306 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46816 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.48599 | 21 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.48739 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.46581 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.65788 | 29 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.48666 | 21 |